News about AstraZeneca
AstraZeneca's big cancer immunotherapy bet is off
An end to Obamacare and a less aggressive approach to drug pricing expected
What kind of deals do you do when your HQ is already outside the U.S.?
The two European companies will share details on 210,000 compounds from their respective research libraries.